Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Understanding the Mechanisms by Which Epigenetic Modifiers Avert Therapy Resistance in Cancer

24 Jun 2020

Abstract excerpt

The development of resistance to anti-cancer therapeutics remains one of the core issues preventing the improvement of survival rates in cancer. Therapy resistance can arise in a multitude of ways, including the accumulation of epigenetic alterations in cancer cells. By remodeling DNA methylation patterns or modifying histone proteins during oncogenesis, cancer cells reorient their epigenomic landscapes in order...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autophagy in Disease and Therapy
Share to Epigenetics and DNA Methylation
Share to Histone Deacetylase Inhibitors Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32670880
DOI: 10.3389/fonc.2020.00992

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Understanding the Mechanisms by Which Epigenetic Modifiers Avert Therapy Resistance in CancerPMID 32670880Read ↗

The cancer epigenome: Concepts, challenges, and therapeutic opportunities.Semantic proximity Read ↗

Epigenetics and OncologySemantic proximity Read ↗

The pharmacoepigenetic paradigm in cancer treatmentSemantic proximity Read ↗

Epigenetic Therapy: Histone Acetylation, DNA Methylation and Anti-Cancer Drug DiscoverySemantic proximity Read ↗

Understanding and Targeting the Epigenetic Regulation to Overcome EGFR-TKIs Resistance in Human Cancer.Semantic proximity Read ↗

DNA Methylation: From Cancer Biology to Clinical PerspectivesSemantic proximity Read ↗

The paradigm of drug resistance in cancer: an epigenetic perspectiveSemantic proximity Read ↗

Epigenome: a new target in cancer therapy.Semantic proximity Read ↗

Drug resistance mechanisms in cancers: Execution of pro-survival strategiesSemantic proximity Read ↗

Towards targeted epigenetic therapy of cancer.Semantic proximity Read ↗

The role of DNA methylation in the pathogenesis and treatment of cancer.Semantic proximity Read ↗

DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical applicationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.